AOCI at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s AOCI?
- Kyverna Therapeutics, Inc. (KYTX) reported AOCI of -$96K in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s AOCI changed year-over-year?
- Kyverna Therapeutics, Inc.'s AOCI decreased by 9500.0% year-over-year, from -$1K to -$96K.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s AOCI?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s AOCI has grown at a 392.4% compound annual growth rate (CAGR), from $4K to $97K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.